Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome

Aim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods: In total, 32 participants received eprosartan (600 mg/d) for 4 months. Dynamics of lipid peroxidation in plasma and platel...

Full description

Bibliographic Details
Main Authors: I. N. Medvedev, T. A. Kumova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2008-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1525
_version_ 1797857213451075584
author I. N. Medvedev
T. A. Kumova
author_facet I. N. Medvedev
T. A. Kumova
author_sort I. N. Medvedev
collection DOAJ
description Aim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods: In total, 32 participants received eprosartan (600 mg/d) for 4 months. Dynamics of lipid peroxidation in plasma and platelets, antioxidant potential of blood serum and platelets, intravascular platelet activity were assessed. The data were analyzed using Student’s t test. Results: In individuals with AH and MS, eprosartan therapy reduced lipid peroxidation and optimized intravascular platelet activity. Long?term eprosartan treatment could strengthen this beneficial effect. Conclusion. To decrease body weight in persons with AH and MS, eprosartan should be combined with non?pharmaceutical methods.
first_indexed 2024-04-09T20:53:06Z
format Article
id doaj.art-4c34b509f8b8449dbef94e90707b26c7
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:53:06Z
publishDate 2008-02-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-4c34b509f8b8449dbef94e90707b26c72023-03-29T21:23:15Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202008-02-010140421310Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndromeI. N. Medvedev0T. A. Kumova1Курский институт социального образования – филиал Российского государственного университетаКурский институт социального образования – филиал Российского государственного университетаAim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods: In total, 32 participants received eprosartan (600 mg/d) for 4 months. Dynamics of lipid peroxidation in plasma and platelets, antioxidant potential of blood serum and platelets, intravascular platelet activity were assessed. The data were analyzed using Student’s t test. Results: In individuals with AH and MS, eprosartan therapy reduced lipid peroxidation and optimized intravascular platelet activity. Long?term eprosartan treatment could strengthen this beneficial effect. Conclusion. To decrease body weight in persons with AH and MS, eprosartan should be combined with non?pharmaceutical methods.https://russjcardiol.elpub.ru/jour/article/view/1525arterial hypertensionmetabolic syndromeplateletseprosartan
spellingShingle I. N. Medvedev
T. A. Kumova
Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
Российский кардиологический журнал
arterial hypertension
metabolic syndrome
platelets
eprosartan
title Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
title_full Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
title_fullStr Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
title_full_unstemmed Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
title_short Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
title_sort eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
topic arterial hypertension
metabolic syndrome
platelets
eprosartan
url https://russjcardiol.elpub.ru/jour/article/view/1525
work_keys_str_mv AT inmedvedev eprosartaneffectsonintravascularplateletactivityinpatientswitharterialhypertensionandmetabolicsyndrome
AT takumova eprosartaneffectsonintravascularplateletactivityinpatientswitharterialhypertensionandmetabolicsyndrome